Back to search

Article

Criterios de selección y factores pronósticos para la cirugía citorreductora (CRS) más quimioterapia intraperitoneal hipertérmica (HIPEC) en el cáncer gástrico con metástasis peritoneales: una revisión sistemática

2026-06-16

Abstract excerpt

Peritoneal dissemination of gastric adenocarcinoma imposes a phenotype highly resistant to conventional systemic regimens. Following the PRISMA 2020 guidelines and the PROSPERO protocol (CRD420261412861), a critical review was conducted to elucidate eligibility criteria and prognostic determinants in adults undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). The...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
537f6368-bf90-57a6-8f6e-f0e88c8a27b8
DOI
10.1590/scielopreprints.16443
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Criterios de selección y factores pronósticos para la cirugía citorreductora (CRS) más quimioterapia intraperitoneal hipertérmica (HIPEC) en el cáncer gástrico con metástasis peritoneales: una revisión sistemáticaDOI 10.1590/scielopreprints.16443
Select a neighboring publication to make it the new centre.